Xeris Biopharma Holdings Inc (XERS)
2.87
+0.04
(+1.41%)
USD |
NASDAQ |
Sep 27, 16:00
2.87
0.00 (0.00%)
After-Hours: 20:00
Xeris Biopharma Holdings Shares Outstanding: 149.00M for July 31, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
July 31, 2024 | 149.00M |
June 30, 2024 | 148.94M |
April 30, 2024 | 148.26M |
April 12, 2024 | 148.25M |
March 31, 2024 | 148.22M |
February 29, 2024 | 140.45M |
December 31, 2023 | 138.13M |
October 31, 2023 | 138.12M |
September 30, 2023 | 138.07M |
July 31, 2023 | 138.07M |
June 30, 2023 | 138.01M |
May 01, 2023 | 137.31M |
April 12, 2023 | 137.31M |
March 31, 2023 | 137.29M |
February 28, 2023 | 137.29M |
December 31, 2022 | 136.27M |
October 31, 2022 | 135.99M |
September 30, 2022 | 135.96M |
July 31, 2022 | 135.96M |
June 30, 2022 | 135.92M |
April 30, 2022 | 135.53M |
April 12, 2022 | 135.53M |
March 31, 2022 | 135.53M |
February 28, 2022 | 135.52M |
January 25, 2022 | 135.11M |
Date | Value |
---|---|
December 31, 2021 | 124.87M |
October 31, 2021 | 124.71M |
October 05, 2021 | 124.58M |
September 30, 2021 | 66.50M |
July 31, 2021 | 66.50M |
July 28, 2021 | 66.50M |
July 22, 2021 | 66.50M |
July 21, 2021 | 66.50M |
June 30, 2021 | 66.50M |
May 21, 2021 | 66.37M |
April 30, 2021 | 66.36M |
April 19, 2021 | 66.33M |
March 31, 2021 | 66.33M |
March 15, 2021 | 66.32M |
March 11, 2021 | 59.76M |
February 28, 2021 | 59.76M |
December 31, 2020 | 59.61M |
October 31, 2020 | 48.98M |
September 30, 2020 | 46.66M |
August 12, 2020 | 46.28M |
July 31, 2020 | 46.28M |
July 15, 2020 | 46.11M |
June 30, 2020 | 45.15M |
June 22, 2020 | 37.60M |
April 30, 2020 | 37.59M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
26.95M
Minimum
Sep 30 2019
149.00M
Maximum
Jul 31 2024
90.85M
Average
66.50M
Median
Jun 30 2021
Shares Outstanding Benchmarks
Zoetis Inc | 453.05M |
Zevra Therapeutics Inc | 52.62M |
NovaBay Pharmaceuticals Inc | 4.886M |
Palatin Technologies Inc | 19.37M |
iBio Inc | 8.638M |